References
- Heuring R. E., Peroutka S. J. Characterisation of a novel [3H]-5-hydroxytryptamine binding site subtype in bovine brain membranes. J. Neurosci. 1987; 7: 894–903
- Waeber C, Schoeffter P., Palacios J. M., Hoyer D. Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human. pig and calf membranes. Naunyn Schmiedeberg's Arch. Pharmacol. 1988; 337: 595–601
- Hoyer D., Schoeffter P. 5-HT1D receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in calf substantia nigra. Eur. J. Pharmacol. 1988; 147: 145–147
- Hoyer D., Middlemiss D. N. The pharmacology of the terminal 5-HT autoreceptors in mammalian brain: evidence for species differences. TiPS 1989; 10: 130–132
- Hamblin M. W., Metcalf M. A. Primary structure and functional characterisation of a human 5-HT1D-type serotonin receptor. Mol. Pharmacol. 1991; 40: 143–148
- Weinshank R. L., Zgombick J. M., Macchi M. J., Brancheck T. A., Hartig P. R. Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1Dα and 5-HT1Dβ. Proc. Natl. Acad. Sci. 1992; 89: 3630–3634
- Weinshank R. L., Branchek T., Hartig P. R. DNA encoding human 5-HT1D receptors and uses thereof. International Patent. no. WO 91/17174, 1991
- Levy F. O., Guderman T., Perez-Reyes E., Birnbaumer M., Kauman A. J., Birnbaumer L. Molecular cloning of a human serotonin receptor (S12) with a pharmacological profile resembling that of the 5-HT1D subtype. J. Biol. Chem. 1992; 267(11)7553–7562
- Lazareno S., Farries T., Birdsall N. J.M. Pharmacological characterisation of guanine-nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors M1-M4. Life Sci. 1993; 52: 449–456
- Kauman A. J., Parsons A. A., Brown A. M. Human arterial constrictor serotonin receptors. Cardiovascular Res. 1993; 27: 2094–2103
- Hilf G., Jakobs K. H. Agonist-independent inhibition of G-protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes. Eur. J. Pharmacol. 1992; 225: 245–252
- Schutz W., Freismuth F. Reverse intrinsic activity of antagonists on G-protein coupled receptors. TiPS. 1992; 13: 376–380
- Maximum binding capacity (Bmax) values for the 5-HT1Dα and 5-HT1Dβ receptors were 5.0 and 0.61 pmoles/mg protein respectively